[Incretin research in the development of new strategies of diabetes therapy].
Göke
B
B
Klinische Forschergruppe für Gastrointestinale Endokrinologie, Philipps Universität Marburg.
Göke
R
R
Fehmann
H C
HC
Arnold
R
R
D000595:Amino Acid Sequence; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D005934:Glucagon / Q000235:genetics / Q000502:physiology; D052216:Glucagon-Like Peptide 1; D000067757:Glucagon-Like Peptide-1 Receptor; D004763:Glucagon-Like Peptides; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000502:physiology; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000235:genetics / Q000502:physiology; D010455:Peptides / Q000235:genetics / Q000502:physiology*; D011498:Protein Precursors / Q000235:genetics / Q000502:physiology; D018027:Receptors, Glucagon / Q000235:genetics
D001786:Blood Glucose; C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D007328:Insulin; D010446:Peptide Fragments; D010455:Peptides; D011498:Protein Precursors; D018027:Receptors, Glucagon; C055453:glucagon-like peptide 1 (7-36)amide; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1; D005934:Glucagon
Inkretinforschung zur Entwicklung neuer Strategien bei der Diabetestherapie.